Delivery Order SPE2DB22D1017-SPE2DB25FYSHS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,214.36 to AmerisourceBergen Drug Corp for 100 capsules of Prograf 1 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and autoimmune disease...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) with a ceiling value of $1,303.59. This firm fixed-price delivery order, awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a direct fulfillment from AmerisourceBergen's existing contract vehicle. The award was made through open competition with no set-aside designation, and performance will take place at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,738.12 to AmerisourceBergen Drug Corp for 100 capsules of Prograf 1 mg on September 11, 2025, with completion anticipated by September 12, 2025. This competitively awarded, firm fixed price contract involves no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Prograf (tacrolimus) is an immunosuppressant medication commonly used in organ transplant recipients and other...
- The Defense Logistics Agency awarded a $18,879.92 delivery order to AmerisourceBergen Drug Corp for Prograf 1 mg capsules (100-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and autoimmune disease management, representing part...
- This delivery order, awarded September 9, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 100 capsules of Prograf 1 mg, an immunosuppressant medication, with a ceiling value of $3,954.26 and completion date of September 10, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $27,638.41 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) with a completion date of August 25, 2025. This is a firm fixed-price delivery order under a non-set-aside competition, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $41,735.37 to AmerisourceBergen Drug Corp for the supply of Prograf 5 mg capsules (100 count units) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a competitively awarded transaction for a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,607.93 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units). This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive set-aside procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $106,966.00 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units). This firm fixed-price, competitively awarded contract, with no set-aside designation, was finalized on September 22, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $36,127.45 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSHSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Prograf 5 mg capsules (100-count) with a contract ceiling value of $4,252.15. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is non-set-aside and was competitively awarded, reflecting AmerisourceBergen's established capability to meet federal procurement requirements through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and dermatological applications, and its procurement through this federal contract supports ongoing military medical readiness and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 9/29/25 |